Doctor profile · Federal record
Dr. Richa Redhu Gehlaut, M.D
Endocrinology, Diabetes & Metabolism Physician (CMS: Internal Medicine) · Shelby Twp, MI
- NPI 1942413588
- Accepts Medicare
- 25 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2177 Auburn RD Ste A
Shelby Twp, MI 483173813
(586) 737-7520
fax (888) 370-6248
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- January 28, 2021
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Michigan #4301500906
- Medicaid
- OH #2932536
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1942413588. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
637
Distinct HCPCS
6
Medicare allowed
$54,806
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 331 | 162 | $128 | |
83036 |
Hemoglobin a1c level | 170 | 91 | $9 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 73 | 42 | $33 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 23 | 23 | $170 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 22 | 21 | $89 | |
95250 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 18 | 17 | $145 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 339. This provider delivers 1.9× the peer median.Open Payments
Industry payments received
All-time total
$1,335
Transactions
65
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 19 | $295.29 | |
| Novo Nordisk Inc | 13 | $202.50 | |
| Corcept Therapeutics | 5 | $122.28 | |
| Xeris Pharmaceuticals, Inc. | 4 | $80.64 | |
| ABBVIE INC. | 3 | $76.29 | |
| Amgen Inc. | 4 | $72.14 | |
| SANOFI-AVENTIS U.S. LLC | 3 | $70.91 | |
| Antares Pharma, Inc. | 3 | $59.91 | |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42.89 | |
| Dexcom, Inc. | 2 | $38.78 | |
| Medtronic, Inc. | 2 | $37.15 | |
| Chiesi USA, Inc. | 2 | $36.07 | |
| RECORDATI_RARE_DISEASES_INC. | 1 | $27.13 | |
| Alexion Pharmaceuticals, Inc. | 1 | $26.28 | |
| Tandem Diabetes Care, Inc. | 1 | $24.32 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
919
Patients
279
Total drug cost
$567,699
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 152 | 40 | $209,330 |
| Jardiance (Empagliflozin) | Brand | 127 | 35 | $138,178 |
| Levothyroxine Sodium | Generic | 123 | 45 | $2,045 |
| Metformin Hcl | Generic | 84 | 37 | $1,015 |
| Glipizide | Generic | 64 | 28 | $750 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 54 | 20 | $36,144 |
| Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 47 | 20 | $6,160 |
| Glimepiride | Generic | 45 | 17 | $1,323 |
| Novolog Flexpen (Insulin Aspart) | Brand | 42 | 15 | $50,126 |
| Toujeo Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 38 | 11 | $27,725 |
Hospital affiliations
Frequently asked questions
What is Dr. Richa Redhu Gehlaut's medical specialty?
Dr. Richa Redhu Gehlaut practices Endocrinology, Diabetes & Metabolism Physician in Shelby Twp, MI.
Where does Dr. Richa Redhu Gehlaut practice?
Dr. Richa Redhu Gehlaut practices at 2177 Auburn RD Ste A, Shelby Twp, MI 483173813. Office phone: 5867377520.
What is Dr. Richa Redhu Gehlaut's NPI?
Dr. Richa Redhu Gehlaut's National Provider Identifier (NPI) is 1942413588, issued by NPPES.
Does Dr. Richa Redhu Gehlaut accept Medicare assignment?
Yes. Dr. Richa Redhu Gehlaut accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Richa Redhu Gehlaut commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Hemoglobin a1c level (HCPCS 83036); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.